← Back to Search

2-Octyl Cyanoacrylate for Scar

N/A
Waitlist Available
Led By Daniel Eisen, MD
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a special medical glue called Dermabond on patients who have had skin surgeries on their head and neck. The glue is applied on top of the wound to help seal it and possibly improve how the scar looks. Researchers want to see if using this glue makes wound care easier and if patients prefer it over traditional stitches. Dermabond is known for its strong bonding, water-resistant properties, and good cosmetic outcomes.

Eligible Conditions
  • Scar tissue

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Scar Assessment as measured by Patient Observer Scar Assessment Score (POSAS)
Width of Scar as measured using Trace-to-Tape Method
Secondary study objectives
Complications or Adverse Events from Treatment

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Layered Closure with 2-Octyl CyanoacrylateExperimental Treatment1 Intervention
One half of the wound will have a cutaneous layer of sutures (2 layers), as is standard of care, while the other half of the wound will have an additional layer of 2-octyl cyanoacrylate (3 layers).
Group II: Layered ClosureActive Control1 Intervention
One half of the wound will have a cutaneous layer of sutures (2 layers), as is standard of care, while the other half of the wound will have an additional layer of 2-octyl cyanoacrylate (3 layers).

Find a Location

Who is running the clinical trial?

University of California, DavisLead Sponsor
945 Previous Clinical Trials
4,756,090 Total Patients Enrolled
Daniel Eisen, MDPrincipal InvestigatorUniversity of California, Davis
10 Previous Clinical Trials
577 Total Patients Enrolled

Media Library

2-Octyl cyanoacrylate Clinical Trial Eligibility Overview. Trial Name: NCT05449457 — N/A
Scar tissue Research Study Groups: Layered Closure, Layered Closure with 2-Octyl Cyanoacrylate
Scar tissue Clinical Trial 2023: 2-Octyl cyanoacrylate Highlights & Side Effects. Trial Name: NCT05449457 — N/A
2-Octyl cyanoacrylate 2023 Treatment Timeline for Medical Study. Trial Name: NCT05449457 — N/A
~16 spots leftby Dec 2025